SCHEMBL14157577

SCHEMBL14157577

NC(=O)C12CC3CC(C1)C(NC(=O)c1ccc(Cc4ccc(Cl)cc4)[nH]1)C(C3)C2

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 20/20 0.52
▸ HSD11B2 P80365 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14157678 0.90 HSD11B1 (0.52) HSD11B1
SCHEMBL14157627 0.89 HSD11B1 (0.52) HSD11B1
SCHEMBL14157714 0.85 HSD11B1 (0.50) HSD11B1HSD11B2
SCHEMBL14157644 0.82 HSD11B1 (0.54) HSD11B1
SCHEMBL14157654 0.75 NPC1 (0.58) HSD11B1HSD11B2
SCHEMBL15706769 0.75 NPC1 (0.58) HSD11B1HSD11B2
SCHEMBL2021300 0.73 HSD11B1 (0.61) HSD11B1HSD11B2
SCHEMBL2027177 0.72 HSD11B1 (0.60) HSD11B1HSD11B2
SCHEMBL2019921 0.71 HSD11B1 (0.59) HSD11B1HSD11B2
SCHEMBL14157730 0.71 HSD11B1 (0.53) HSD11B1HSD11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2699560-A2 5-CARBAMOYL-ADAMANTAN-2-YL AMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND PREPARATION PROCESS THEREOF SK Biopharmaceuticals Co., Ltd. (KR) 2014-02-26 — — EP claimed
WO-2012169863-A2 5-CARBAMOYL-ADAMANTAN-2-YL AMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND PREPARATION PROCESS THEREOF SK BIOPHARMACEUTICALS CO., LTD. (KR) 2012-12-13 — — WO claimed
EP-2699560-A2 5-CARBAMOYL-ADAMANTAN-2-YL AMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND PREPARATION PROCESS THEREOF SK Biopharmaceuticals Co., Ltd. (KR) 2014-02-26 — — EP disclosed
WO-2012169863-A2 5-CARBAMOYL-ADAMANTAN-2-YL AMIDE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AND PREPARATION PROCESS THEREOF SK BIOPHARMACEUTICALS CO., LTD. (KR) 2012-12-13 — — WO disclosed
Send feedback